These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2451713)

  • 41. Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study.
    Fesneau M; Pointreau Y; Chapet S; Martin L; Pommier P; Alfonsi M; Laguerre B; Feham N; Berger C; Garaud P; Calais G
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):154-63. PubMed ID: 19386430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
    Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E
    J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.
    Mesía R; Vázquez S; Grau JJ; García-Sáenz JA; Lozano A; García C; Carles J; Irigoyen A; Mañós M; García-Paredes B; del Barco E; Taberna M; Escobar Y; Cruz JJ;
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):289-96. PubMed ID: 26675064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant chemotherapy in stage III and IV squamous cell carcinoma of the head and neck.
    Klima A; Klippstein T; Bergmann L; Szepesi S; Ilberg CV
    J Laryngol Otol; 1988 Apr; 102(4):337-40. PubMed ID: 2455011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program.
    Jacobs C; Makuch R
    J Clin Oncol; 1990 May; 8(5):838-47. PubMed ID: 2185340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.
    Merlano M; Vitale V; Rosso R; Benasso M; Corvò R; Cavallari M; Sanguineti G; Bacigalupo A; Badellino F; Margarino G
    N Engl J Med; 1992 Oct; 327(16):1115-21. PubMed ID: 1302472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer.
    Ensley J; Kish J; Tapazoglou E; Jacobs J; Weaver A; Atkinson D; Ahmed K; Mathog R; Al-Sarraf M
    J Clin Oncol; 1988 Jul; 6(7):1147-53. PubMed ID: 3292714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.
    Denis F; Garaud P; Bardet E; Alfonsi M; Sire C; Germain T; Bergerot P; Rhein B; Tortochaux J; Calais G
    J Clin Oncol; 2004 Jan; 22(1):69-76. PubMed ID: 14657228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemotherapy strategies in squamous cell carcinoma of the head and neck.
    Al-Sarraf M
    Crit Rev Oncol Hematol; 1984; 1(4):323-55. PubMed ID: 6085038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neoadjuvant and concomitant chemotherapy and radiation therapy in patients with advanced head and neck carcinoma.
    Rinehart J; Ruff T; Cheung A; Hutchinson L; Tuggle R; Pinkston DR; Keville L; Wong L
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):69-74. PubMed ID: 15632912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.
    Clark JR; Busse PM; Norris CM; Andersen JW; Dreyfuss AI; Rossi RM; Poulin MD; Colevas AD; Tishler RB; Costello R; Lucarini JW; Lucarini D; Thornhill L; Lackey M; Peters E; Posner MR
    J Clin Oncol; 1997 Sep; 15(9):3100-10. PubMed ID: 9294473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
    Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; de Graeff A; Clavel M
    J Clin Oncol; 1995 Jul; 13(7):1649-55. PubMed ID: 7602354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A; Cummings G; Al-Sarraf M
    Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer.
    Adelstein DJ; Sharan VM; Earle AS; Shah AC; Vlastou C; Haria CD; Damm C; Carter SG; Hines JD
    Cancer; 1990 Apr; 65(8):1685-91. PubMed ID: 2317751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction chemotherapy in advanced head and neck cancer. Preliminary results of a randomized study.
    Brunin F; Rodriguez J; Jaulerry C; Jouve M; Pontvert D; Point D; Mosseri V; Pouillart P; Asselain B; Brugere J
    Acta Oncol; 1989; 28(1):61-5. PubMed ID: 2650723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized trial of adjuvant chemotherapy in head and neck cancer.
    Taylor SG; Applebaum E; Showel JL; Norusis M; Holinger LD; Hutchinson JC; Murthy AK; Caldarelli DD
    J Clin Oncol; 1985 May; 3(5):672-9. PubMed ID: 3889230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synchronous multiple drug chemotherapy and radiotherapy for advanced (stage III and IV) squamous carcinoma of the head and neck.
    Clifford P; O'Connor AD; Durden-Smith J; Hollis BA; Edwards WG; Dalley VM
    Antibiot Chemother (1971); 1978; 24():60-72. PubMed ID: 77659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.